A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy
PHASE2
First line chemotherapy treatment regimens for metastatic colorectal cancer...
Status
Unknown
Location
Associació Catalana per la Recerca Oncològica i les Seves Implicacions Sanitaries i Socials
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery
PHASE2
RATIONALE: Monoclonal antibodies, such as panitumumab, can block tumor grow...
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
PHASE3
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...